| | | | | Novartis is halting early-stage research in Shanghai and shifting the site's focus to commercial development three years after the Swiss drugmaker christened the new $1 billion campus as its Chinese drug discovery hub. | | |
| | | Merck & Co Inc said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study. | | |
| | | The Indian government has told a court that its federal ban on the sale of electronic cigarettes implies that their use is also prohibited, legal documents seen by Reuters showed, in a further clampdown on the devices. | | |
| | | China's Inner Mongolia reported a fresh, confirmed case of bubonic plague on Sunday, despite an earlier declaration by the country's health officials that the risk of an outbreak was minimal. | | |
| | | China reported a third case of bubonic plague on Sunday after two other plague cases were revealed last week, but the disease remains rare despite its fearsome reputation and authorities say the cases appear unrelated. | | |
| | | China's agriculture ministry said on Monday it will launch an investigation into the illegal production, sale and use of African swine fever vaccines in the country, citing online reports of their use by some farmers. | | |
| | | Samoa declared a state of emergency this weekend, closing all schools and cracking down on public gatherings, after several deaths linked to a measles outbreak that has spread across the Pacific islands. | | |
| | | Many patients with severe but stable heart disease who routinely undergo invasive procedures to clear and prop open clogged arteries would do as well by just taking medications and making lifestyle changes, U.S. researchers reported on Saturday. | | |
| | | (The Nov 16 story corrects to clarify in second graph that patients will be infused by a healthcare provider.) | | |
| | | An Oklahoma judge on Friday said Johnson & Johnson must pay that state $465 million for fueling the opioid epidemic through the deceptive marketing of painkillers, down from his original award of $572 million. | | |
| | | China-based drugmaker BeiGene Ltd on Friday priced its drug, Brukinsa, to treat a rare form of lymphoma at $12,935 for a 30-day supply. | | |
|
| |
